Total Payments
$15,031
2024 Payments
$2,004
Companies
56
Transactions
777
Medicare Patients
5,471
Medicare Billing
$490,408
Payment Breakdown by Category
Food & Beverage$15,014 (99.9%)
Education$16.92 (0.1%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $15,014 | 775 | 99.9% |
| Education | $16.92 | 2 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $2,246 | 139 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $2,144 | 125 | $0 (2024) |
| ABIOMED | $1,395 | 12 | $0 (2022) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,068 | 65 | $0 (2024) |
| Philips Electronics North America Corporation | $704.66 | 83 | $0 (2023) |
| Mylan Specialty L.P. | $589.28 | 24 | $0 (2024) |
| Actelion Pharmaceuticals US, Inc. | $523.57 | 29 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $503.49 | 20 | $0 (2024) |
| Genentech USA, Inc. | $484.51 | 37 | $0 (2022) |
| Merck Sharp & Dohme LLC | $478.02 | 24 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,004 | 87 | AstraZeneca Pharmaceuticals LP ($391.23) |
| 2023 | $2,288 | 103 | AstraZeneca Pharmaceuticals LP ($404.11) |
| 2022 | $1,916 | 96 | GlaxoSmithKline, LLC. ($269.45) |
| 2021 | $1,354 | 59 | ABIOMED ($345.90) |
| 2020 | $1,980 | 85 | ABIOMED ($695.31) |
| 2019 | $2,195 | 136 | AstraZeneca Pharmaceuticals LP ($314.58) |
| 2018 | $1,981 | 122 | GlaxoSmithKline, LLC. ($268.50) |
| 2017 | $1,312 | 89 | Respiratory Technologies, Inc. ($347.31) |
All Payment Transactions
777 individual payment records from CMS Open Payments — Page 1 of 32
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $29.91 | General |
| Category: NEUROLOGY | ||||||
| 12/10/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $14.96 | General |
| Category: Respiratory | ||||||
| 12/09/2024 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Food and Beverage | In-kind items and services | $28.48 | General |
| Category: Cardiology | ||||||
| 12/04/2024 | United Therapeutics Corporation | TYVASO (Drug) | Food and Beverage | In-kind items and services | $28.45 | General |
| Category: Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lung Disease | ||||||
| 12/02/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $20.68 | General |
| Category: IMMUNOLOGY | ||||||
| 11/08/2024 | Baxter Healthcare | Hillrom - Vest System Model 105 Home Care (Device) | Food and Beverage | In-kind items and services | $25.33 | General |
| Category: Airway Clearance Device | ||||||
| 11/04/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $23.75 | General |
| Category: IMMUNOLOGY | ||||||
| 10/28/2024 | Pulmonx Corporation | CHARTIS CATHETER (Device), ZEPHYR DELIVERY CATHETER, ZEPHYR ENDOBRONCHIAL VALVE | Food and Beverage | In-kind items and services | $31.56 | General |
| Category: PULMONOLOGY | ||||||
| 10/23/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $15.26 | General |
| Category: Respiratory | ||||||
| 10/21/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $27.39 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 10/16/2024 | Pulmonx Corporation | CHARTIS CATHETER (Device), ZEPHYR DELIVERY CATHETER, ZEPHYR ENDOBRONCHIAL VALVE | Food and Beverage | In-kind items and services | $15.47 | General |
| Category: PULMONOLOGY | ||||||
| 10/03/2024 | Takeda Pharmaceuticals U.S.A., Inc. | GLASSIA (Biological) | Food and Beverage | In-kind items and services | $31.65 | General |
| Category: IMMUNOLOGY | ||||||
| 10/02/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $27.41 | General |
| Category: IMMUNOLOGY | ||||||
| 10/01/2024 | Merck Sharp & Dohme LLC | WINREVAIR (Biological) | Food and Beverage | In-kind items and services | $28.62 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/30/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $29.76 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 09/24/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $23.70 | General |
| Category: Respiratory | ||||||
| 09/16/2024 | Philips North America LLC | (AK6) Vest Therapy (Device) | Food and Beverage | Cash or cash equivalent | $28.77 | General |
| Category: Medical Device | ||||||
| 09/13/2024 | Baxter Healthcare | Hillrom - Vest System Model 105 Home Care (Device) | Food and Beverage | In-kind items and services | $23.35 | General |
| Category: Airway Clearance Device | ||||||
| 09/12/2024 | Merck Sharp & Dohme LLC | ZERBAXA (Drug) | Food and Beverage | In-kind items and services | $20.98 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 09/11/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $29.11 | General |
| Category: RESPIRATORY | ||||||
| 09/10/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $17.63 | General |
| Category: RESPIRATORY | ||||||
| 09/09/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $26.14 | General |
| Category: IMMUNOLOGY | ||||||
| 09/06/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $18.08 | General |
| Category: IMMUNOLOGY | ||||||
| 09/05/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $16.72 | General |
| Category: Respiratory | ||||||
| 09/04/2024 | INOGEN, INC. | INOGEN ONE G5 OXYGEN CONCENTRATOR - BLUETOOTH (Device) | Food and Beverage | Cash or cash equivalent | $24.66 | General |
| Category: OXYGEN CONCENTRATOR | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 890 | 1,662 | $248,618 | $123,077 |
| 2022 | 19 | 1,022 | 1,709 | $259,531 | $122,661 |
| 2021 | 15 | 1,758 | 2,211 | $275,772 | $135,375 |
| 2020 | 17 | 1,801 | 2,185 | $244,605 | $109,296 |
Total Patients
5,471
Total Services
7,767
Medicare Billing
$490,408
Procedure Codes
78
All Medicare Procedures & Services
78 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 292 | 539 | $87,857 | $51,178 | 58.3% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 61 | 123 | $51,537 | $21,375 | 41.5% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 63 | 145 | $23,200 | $13,921 | 60.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 50 | 67 | $14,740 | $8,218 | 55.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 115 | 125 | $13,750 | $7,069 | 51.4% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 29 | 190 | $19,000 | $7,069 | 37.2% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 27 | 176 | $18,656 | $6,357 | 34.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 36 | 36 | $9,000 | $3,997 | 44.4% |
| 99458 | Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | Office | 2023 | 19 | 59 | $5,015 | $1,845 | 36.8% |
| 94618 | Test for exercise-induced lung stress | Office | 2023 | 28 | 29 | $2,037 | $555.70 | 27.3% |
| 94726 | Test to determine lung volumes using sensors | Office | 2023 | 39 | 39 | $741.00 | $359.86 | 48.6% |
| 99406 | Smoking and tobacco use intensive counseling, 4-10 minutes | Office | 2023 | 19 | 22 | $660.00 | $326.48 | 49.5% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 39 | 39 | $780.00 | $317.07 | 40.7% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 45 | 45 | $675.00 | $311.08 | 46.1% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2023 | 14 | 14 | $210.00 | $91.91 | 43.8% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 14 | 14 | $760.00 | $84.89 | 11.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 263 | 436 | $71,068 | $40,183 | 56.5% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 97 | 172 | $72,068 | $29,496 | 40.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 153 | 169 | $18,590 | $10,457 | 56.3% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 76 | 123 | $19,680 | $10,263 | 52.2% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2022 | 33 | 199 | $19,900 | $7,655 | 38.5% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2022 | 29 | 171 | $18,126 | $6,965 | 38.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 23 | 31 | $6,820 | $4,163 | 61.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 30 | 30 | $7,500 | $3,596 | 47.9% |
| 99458 | Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | Office | 2022 | 27 | 84 | $7,140 | $2,677 | 37.5% |
About Dr. Mark Crowe, MD
Dr. Mark Crowe, MD is a Internal Medicine healthcare provider based in Jacksonville, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/06/2006. The National Provider Identifier (NPI) number assigned to this provider is 1598743791.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mark Crowe, MD has received a total of $15,031 in payments from pharmaceutical and medical device companies, with $2,004 received in 2024. These payments were reported across 777 transactions from 56 companies. The most common payment nature is "Food and Beverage" ($15,014).
As a Medicare-enrolled provider, Crowe has provided services to 5,471 Medicare beneficiaries, totaling 7,767 services with total Medicare billing of $490,408. Data is available for 4 years (2020–2023), covering 78 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Critical Care Medicine, Pulmonary Disease
- Location Jacksonville, FL
- Active Since 01/06/2006
- Last Updated 08/18/2025
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1598743791
Products in Payments
- Impella (Device) $1,395
- NUCALA (Biological) $1,072
- DUPIXENT (Biological) $792.21
- TRELEGY ELLIPTA (Drug) $659.83
- OFEV (Drug) $621.82
- TEZSPIRE (Biological) $448.64
- SYMBICORT (Drug) $408.97
- FASENRA (Biological) $358.08
- FASENRA (Drug) $339.32
- Yupelri (Drug) $315.84
- (8874) inCourage (Device) $314.69
- Xolair (Biological) $305.95
- ACTHAR (Biological) $297.45
- OPSUMIT (Drug) $280.69
- TYVASO (Drug) $254.39
- BREO (Drug) $247.61
- GLASSIA (Biological) $246.78
- XYWAV (Drug) $236.16
- YUPELRI (Drug) $234.91
- BREZTRI (Drug) $232.53
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Jacksonville
Siddharth Wayangankar, Md, MD
Internal Medicine — Payments: $1.3M
Internal Medicine $1.3M
Dr. Alan Miller, M.d, M.D
Internal Medicine — Payments: $770,575
Internal Medicine $770,575
Kalina Sanders, M.d, M.D
Internal Medicine — Payments: $626,907
Internal Medicine $626,907
Jose Soto Soto, Md, MD
Internal Medicine — Payments: $576,809
Internal Medicine $576,809
Dr. Jennifer Fulton, Md, MD
Internal Medicine — Payments: $556,016
Internal Medicine $556,016
Dr. Francis Farraye, M.d, M.D
Internal Medicine — Payments: $504,399
Internal Medicine $504,399